Illicit and Counterfeit Drugs Threaten Americans in the GLP-1 Space
Home Study Webinar
$20 Activity Fee
Topic Designator: 05 – Patient Safety | Credit: 1 contact hour Available through August 28, 2028
This presentation will explore a broad continuum of threats to patient safety in the GLP-1 space, from unapproved research chemicals to perfect look-alike counterfeits. It will include an explanation of the Drug Supply Chain Security Act’s labeling requirements and how the system operates. Additionally, the webinar will outline techniques for spotting signs of unsafe medicines and procedures for handling suspect medication.
This home study webinar is a recording of the live activity that was held on August 28, 2025.
Presenter
Shabbir J. Imber Safdar, CFE
Executive Director, Partnership for Safe Medicines
Shabbir Imber Safdar is the executive director of the Partnership for Safe Medicines (PSM), a public health group committed to the safety of prescription drugs and protecting consumers against counterfeit, substandard, or otherwise unsafe medications. Prior to this role, he served as a consultant to PSM for nearly a decade. Mr Imber Safdar is passionate about patient safety and the dangers of counterfeits, having seen firsthand the risks they pose in countries around the world where closed, secure drug supply chains do not exist. In addition to his role at PSM, he hosts two podcasts: Safe Medicines: True Crime and Medicine Safety, which explores crimes and also current and proposed policies that may increase or decrease the danger of counterfeits, and Imitation Nation, which covers all things counterfeit and related news about counterfeit products, seizures, and prosecutions.
